Patent Application
20140323842
The present disclosure relates to biomedical electrodes, and in particular, to an ECG electrode having a radiolucent characteristic and method of making same.
Electrocardiograph (ECG) monitors are widely used to obtain medical (i.e., biopotential) signals containing information indicative of the electrical activity associated with the heart and pulmonary system. To obtain medical signals, ECG electrodes are applied to the skin of a patient in various locations. The electrodes, after being positioned on the patient, connect to an ECG monitor by a set of ECG lead wires. The distal end of the ECG lead wire, or portion closest to the patient, may include a connector which is adapted to operably connect to the electrode to receive medical signals from the body. The proximal end of the ECG lead set is operably coupled to the ECG monitor and supplies the medical signals received from the body to the ECG monitor.
A typical ECG electrode may include a pad having an electrically conductive layer and a backing layer, the pad having a patient contact side and a connector side. The patient contact side of the pad may include a biocompatible conductive gel or adhesive for affixing the electrode to a patient's body for facilitating an appropriate electrical connection between the body and the electrode. The connector side of the pad may incorporate a metallic press stud or snap having a bulbous profile for coupling the electrode to the ECG lead wire. In use, the clinician removes a protective covering from the patient contact side of the pad to expose the gel or adhesive, affixes the electrode to the patient's body, and attaches the appropriate ECG lead wire connector to the press stud by pressing or “snapping” the lead wire connector onto the bulbous press stud to achieve mechanical and electrical coupling of the electrode and lead wire. After use, a clinician then removes the ECG lead wire connector from the pad by pulling or “unsnapping” the connector from the electrode.
An eyelet connects the electrically conductive layer of the electrode with the press stud to provide electrical communication therebetween. Currently available eyelets are either plated or completely coated with a conductive material. Some commercially available eyelets contain a large amount of silver, which may result in poor radiotransparency. Other products in the commercial market use a carbon filled plastic compound to improve radiolucency. However, these parts are also coated with silver material.
It would be advantageous to provide an ECG electrode having improved radiolucency and less silver than current commercially available electrodes.
The present disclosure is directed to an electrode having a radiotranslucent characteristic.
In one embodiment, an electrode comprises a pad including a patient contact side and a connector side, the patient contact side including a conductive layer and the connector side including a press stud; and an eyelet interconnecting the conductive layer with the press stud. The eyelet includes a conductive coating disposed on at least a portion of a surface thereof that contacts the conductive layer, wherein the conductive coating is present on the eyelet in an amount from about 15% of the surface area of the eyelet to about 50% of the surface area of the eyelet.
Another aspect of the disclosure is directed to a method of manufacturing an electrode comprising providing an eyelet, a conductive layer, and a press stud. A conductive coating is applied onto a distal surface of the eyelet. The electrode is assembled such that the distal surface of the eyelet contacts the conductive layer, and a proximal end of the eyelet contacts the press stud.
Other advantages, novel features, and objectives of the present disclosure will become apparent from the following detailed description of the present disclosure when considered in conjunction with the accompanying drawings, which are schematic and not intended to be drawn to scale. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the present disclosure shown where illustration is not necessary to allow those of ordinary skill in the art to understand the present disclosure.
Various embodiments of the presently disclosed ECG electrodes are disclosed herein with reference to the drawings, wherein:
Various exemplary embodiments of the present disclosure are discussed hereinbelow in terms of ECG electrodes for monitoring heart activity and for diagnosing heart abnormalities. It is envisioned, however, that the principles of the present disclosure are equally applicable to other medical electrodes, for example, electroencephalogram (EEG) electrodes; transcutaneous electrical nerve stimulation (TENS) electrodes used for pain management; neuromuscular stimulation (NMS) electrodes used for treating conditions such as scoliosis; muscle stimulation electrodes; wound treatment electrodes (accelerating healing of skin wounds or broken bones); defibrillation electrodes to dispense electrical energy to a chest cavity of a patient to defibrillate heart beats of the patient; iontophoresis; and dispersive electrodes to receive electrical energy dispensed into an incision made during electrosurgery.
In the following discussion, the terms “proximal” and “trailing” may be employed interchangeably, and should be understood as referring to the portion of a structure that is closer to a clinician during proper use. The terms “distal” and “leading” may also be employed interchangeably, and should be understood as referring to the portion of a structure that is further from the clinician during proper use. As used herein, the term “patient” should be understood as referring to a human subject or other animal, and the term “clinician” should be understood as referring to a doctor, nurse, or other care provider and may include support personnel.
“Radiotransparency” may be used interchangeably with “radiolucency”, and refers to the property of an electrode that allows a clinician to leave electrodes in place during radiological (e.g., x-ray) or other imaging examinations, to visualize the tissue underlying the electrode without loss of image quality.
The following discussion includes a description of embodiments of the presently disclosed ECG electrodes, as well as a description of exemplary corresponding methods of coating the same in accordance with the principles of the present disclosure.
Referring now to the figures, where like components are designated by like reference numerals throughout the several view,
The conductive composition 118 on the patient contact side 112 of pad 110 may be temporarily adhered to a release liner 102. Release liner 102 is a release paper or film of a waxed or coated plastic, such as a silicone coated polyethylene terephthalate film, which may be used to protect the patient contact side 112 of the electrode 100 prior to application of the electrode to the patient. The conductive composition 118 may be a conventional conductive gel. Other conductive compositions which may be utilized with the electrode 100 of the present disclosure includes hydrogels, such as, for example, those disclosed in commonly assigned U.S. Patent Application Publication Nos. 2009/0270709, entitled “Novel Electrodes”, and 2010/0059722, entitled “Conductive Compositions and Method”, the entire disclosures of each of which are hereby incorporated by reference Herein.
As shown in
The eyelet 126 may be fabricated of any suitable material. In embodiments, eyelet 126 may be fabricated from plastic. Non-limiting examples of suitable plastic materials from which the eyelet may be fabricated include polyolefins, such as polyethylene and polypropylene, including atactic, isotactic, syndiotactic, and blends and combinations thereof; polyethylene glycols; polyethylene oxides; ultra high molecular weight polyethylene; copolymers of polyethylene and polypropylene, as well as polyisobutylene and ethylene-alpha olefin copolymers; fluorinated polyolefins such as polytetrafluoroethylene and polyfluroroacetal; polyamides such as nylon and polycaprolactam; polyamines; polyimines; polyesters such as polyethylene terephthalate and polybutylene terephthalate; aliphatic polyesters; polyethers such as polyether ether ketone and polyether sulfonates; polyether-esters such as polybutester; polytetramethylene ether glycol; 1,4-butanediol; polyurethanes; acrylic polymers, copolymers, and resins; modacrylics; vinyl halide polymers and copolymers such as polyvinyl chloride; polyvinyl alcohols; polyvinyl ethers such as polyvinyl methyl ether; polyvinylidene halides such as polyvinylidene fluoride and polyvinylidene chloride; polyacrylonitrile; polyvinyl ketones; polyvinyl aromatics such as polystyrene; polyvinyl esters such as polyvinyl acetate; copolymers of vinyl monomers with each other and olefins such as etheylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, and ethylene-vinyl acetate copolymers; alkyd resins; polycarbonates and alloys thereof; polyoxymethylenes; polyacetals; polyphosphazine; polysulfones; polymethylpentene; polyimides; epoxy resins; aramids; and combinations thereof.
In embodiments, the eyelet 126 may include a conductive filler material to enhance the flow of energy therethrough. Fillers include, for example, conductive metal fibers such as silver or tin fibers, and metallic threads, metallic powders, metallic flakes, and metallic spheres. The filler material may be carbon fillers, conductive carbon fiber fillers, acetylene black, chopped polyacrylonitrile fibers, noble metallic particles, noble metal halide particles, and combinations thereof. Suitable thermally conductive compounds include those commercially available, for example, from RTP Company.
In embodiments, the filler material may be admixed with, or impregnated within, the plastic material used to form the eyelet. The eyelet may be loaded with conductive filler material in amounts from about 2% by weight to about 75% by weight of the eyelet, in embodiments, from about 5% by weight to about 50% by weight of the eyelet, and in some embodiments, from about 10% by weight to about 40% by weight of the eyelet.
Alternatively, the plastic material forming the eyelet 126 may itself be conductive. Conductive polymers used to form such an eyelet include, for example, polythiophene, polyacetylene, polyphenylene vinylene, polypyrrole, polyaniline, polyphenylene sulfide, copolymers, and derivatives thereof, among other intrinsically conducting polymers within the purview of those skilled in the art. In embodiments, the conductive polymers may be utilized alone or in combination with conductive filler materials, as described above.
In embodiments, the outer surface of the eyelet 126 includes a topically applied conductive coating 140 that is adjacent to, and in contact with, the conductive layer 116 (or 116a) of the electrode 100 (or 100a). As illustrated in
In embodiments, the conductive coating includes at least one heavy metal and/or heavy metal salt. Suitable heavy metals include, for example, the transition metals such as silver, gold, copper, zinc, cadmium, cobalt, nickel, palladium, and platinum, as well as some metalloids such as tin, bimetal and polymetal complexes, and salts thereof. In embodiments, the at least one heavy metal is silver or tin. Heavy metal salts include, for example, halide salts, such as fluorides, chlorides, bromides, iodides, and astatides of the above metals. Examples of heavy metal salts include, for example, silver salts such as silver acetate, silver carbonate, silver sulfate, silver phosphate, silver chloride, silver bromide, silver fluoride, silver citrate, and silver nitrate; and tin salts such as tin acetate, tin ethylhexanoate, tin sulfate, tin chloride, tin fluoride, tin iodide, tin bromide, and tin oxide, for example.
In embodiments, the heavy metal is coupled with a metal salt. In such embodiments, the metal/metal salt coating should have excellent conductivity. In embodiments, silver/silver chloride, tin/tin chloride, or other silver or tin metal/halide salt combinations may be utilized in the coating of the present disclosure. In some embodiments, a conductive coating containing a heavy metal may be applied to the eyelet and a metal salt complex may be formed by allowing a portion of the metal in the coating to convert into a halide salt by interaction with the conductive layer of the electrode.
In other embodiments, the conductive coating may be applied to the eyelet 126 prior to its use in manufacturing an electrode 100 or 100a. The conductive coating may be applied to the eyelet by any means within the purview of those skilled in the art including: spray coating; ultrasonic spray coating; electrospray coating; solvent/immersion coating such as dipping; solvent evaporation; combinations thereof, and the like. In embodiments, the metal and/or metal salt may be dissolved in any suitable solvent that is compatible with the base material forming the eyelet to accommodate the drying or curing time needed to deposit the coating on the eyelet. After application, the solvent may be evaporated, leaving the heavy metal and/or metal salt coating on the eyelet.
Alternatively, the coating may be applied to the eyelet by melt coating or electrostatic coating, among other techniques within the purview of those skilled in the art.
In embodiments, the conductive coating may include conductive filler materials, such as those described above.
In embodiments, the coating is an electrically conductive ink that may be transferred to the surface of the eyelet by any of a number of transfer, printing, or laminating methods, such as screen printing, pad printing, or hot stamping. Suitable inks, such as silver/silver chloride inks, are commercially available from Ercon Inc. (as ERCON R68 ink) and Henkel Corporation (as ELECTRODAG PE-007 ink).
In embodiments, the conductive coating may be present in an amount from about 1% by weight to about 5% by weight of the eyelet. In one embodiment the conductive coating may be present in an amount of about 2% by weight of the eyelet.
In embodiments, only a portion of the surface of the eyelet may possess a conductive coating thereon. The remaining surface of the eyelet may be substantially free of the conductive composition. For example, in embodiments the conductive composition may be present on the eyelet in an amount from about 15% of the surface area of the eyelet to about 50% of the surface area of the eyelet, in embodiments from about 20% of the surface area of the eyelet to about 45% of the surface area of the eyelet. The conductive coating may by silver chloride with a silver content of about 15% to about 18% silver by weight.
For example, an eyelet may be formed from about a 30% to about a 40% carbon filled plastic. A silver/silver chloride ink is pad printed onto the distal surface of the eyelet. The electrode is then assembled such that the distal surface of the eyelet containing the silver/silver chloride ink contacts the conductive layer of the electrode, and the proximal end of the eyelet, which is free of a conductive coating, contacts the press stud.
In use, the electrodes of the present disclosure have excellent conductivity. In addition, as the electrodes of the present disclosure do not possess eyelets completely coated with a conductive material, such as silver, they have excellent radiotransparency, i.e., radiolucency.
Persons skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments. It is envisioned that the elements and features illustrated or described in connection with one exemplary embodiment may be combined with the elements and features of another without departing from the scope of the present disclosure. As well, the present disclosure is not intended to be limited to the details shown, since it will be understood that various omissions, modifications, substitutions, and changes in the forms and details of the device illustrated and its operation can be made by those skilled in the art without departing in any way from the spirit and scope of the appended claims.
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13249541 | Sep 2011 | US |
| Child | 14264883 | US |
